19 year-old transplant patient sees new face for the first timemsnbc.comThe real impediment would have to be major transplant rejection… "95% chance you'll love your new hair… 4% chance you'll hate the lifelong rejection meds… 1% cha…
Four-Factor Model Predicts Post-Heart Transplant Mortality – Doctors Lounge
Four-Factor Model Predicts Post-Heart Transplant MortalityDoctors LoungeA risk-prediction tool using four factors at the time of transplant can help predict post-transplant mortality for children undergoing heart transplantation, according to a study p…
Organ donation rates go flat – CBC.ca
CBC.caOrgan donation rates go flatCBC.caOrgan donation rates have stagnated in Canada since 2006, according to a new report. The Canadian Institute for Health Information released its annual report on end-stage organ failure on Monday. A kidney transpl…
Memorial Offers Health Briefs For March – The Chattanoogan
Memorial Offers Health Briefs For MarchThe ChattanooganMarch 1 Cardiac: Congestive Heart Failure Education. Free education for patients with congestive heart failure. Chattanooga Heart Institute, 2nd floor. Call 495-7764 for more information. March 2 D…
Heart Failure Patients Have New Hope – MarketWatch (press release)
SeniorJournal.comHeart Failure Patients Have New HopeMarketWatch (press release)DALLAS, Feb 13, 2012 (GlobeNewswire via COMTEX) — More than six million American adults suffer from heart failure. But, while the prevalence of this disease has increased …
Why To Exercise Today: Liver Transplants And Other Ordeals – WBUR
Why To Exercise Today: Liver Transplants And Other OrdealsWBURThe study came out in this month's edition of the journal Liver Transplantation. It performed “cardiopulmonary exercise testing” — heart and lung testing — in patients facing liv…
Study Shows Abbott's Tacrolimus Assay Demonstrates Consistent Organ Transplant … – Bradenton Herald
Study Shows Abbott's Tacrolimus Assay Demonstrates Consistent Organ Transplant …Bradenton Herald13, 2012 /PRNewswire/ — A new study published in the journal Clinical Chemistry reported Abbott's (NYSE: ABT) ARCHITECT® Tacrolimus assay provid…
2012 Economic Outlook — Report Highlights Alexion Pharmaceuticals, Inc. and … – Marketwire (press release)
2012 Economic Outlook — Report Highlights Alexion Pharmaceuticals, Inc. and …Marketwire (press release)… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, includin…
2012 Economic Outlook — Report Highlights Alexion Pharmaceuticals, Inc. and … – MarketWatch (press release)
2012 Economic Outlook — Report Highlights Alexion Pharmaceuticals, Inc. and …MarketWatch (press release)… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, includi…
Study Shows Abbott's Tacrolimus Assay Demonstrates Consistent Organ Transplant … – MarketWatch (press release)
Study Shows Abbott's Tacrolimus Assay Demonstrates Consistent Organ Transplant …MarketWatch (press release)13, 2012 /PRNewswire via COMTEX/ — A new study published in the journal Clinical Chemistry reported Abbott's /quotes/zigman/216393/quo…